Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera

NCT06078319 is registered in ClinicalTrials.gov with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor.

NCT NCT06078319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06078319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase
Observational
Overall status
Completed
Start date
January 18, 2021
Completion date
June 30, 2023
Enrollment
189 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

adherence, patient, adherence, treatment